Unaudited condensed consolidated statements of cash flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 284.8	$ (582.6)
Reconciling adjustments:
Depreciation and amortization	315.9	306.9
Impairment charges	0.0	785.0
Stock-based compensation expense	36.5	35.1
Non-cash restructuring charges	5.0	0.0
Provision for accounts receivable and inventory	46.2	43.4
Deferred income tax benefit	(141.1)	(41.9)
Amortization of deferred financing costs	5.3	6.6
Loss on extinguishment of debt	2.0	0.2
Foreign currency remeasurement (gain) loss	(0.5)	0.7
Pension termination charges	0.0	18.1
Changes in assets and liabilities:
Accounts receivable	(68.3)	10.5
Inventory	(90.8)	(66.7)
Accounts payable	7.5	(4.4)
Accrued interest	(15.8)	(13.4)
Other assets and liabilities	42.9	(27.4)
Other	2.4	1.0
Net cash provided by operating activities	432.0	471.1
Cash flows from investing activities:
Capital expenditures	(110.0)	(93.3)
Other	1.5	2.5
Net cash used in investing activities	(108.5)	(90.8)
Cash flows from financing activities:
Debt borrowings	54.0	67.7
Debt repayments	(280.6)	(477.3)
Proceeds received from exercise of stock options	14.6	4.9
Shares repurchased to satisfy employee tax obligations for vested stock-based awards	(5.0)	(5.4)
Other	(0.8)	0.0
Net cash used in financing activities	(217.8)	(410.1)
Effect of currency rate changes on cash and cash equivalents	(6.8)	19.8
Net change in cash, cash equivalents and restricted cash	98.9	(10.0)
Cash, cash equivalents and restricted cash, beginning of period	368.3	264.7
Cash, cash equivalents and restricted cash, end of period	$ 467.2	$ 254.7